MicroRNA Expression Profiles in Serous Ovarian Carcinoma

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Cancer Research

• Publication date

  2008-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-07-1731PMID 18451233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA signatures in human ovarian cancer.

  2007cited by this paper
• Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b*

  2007cited by this paper
• miR-21-mediated tumor growth

  2007cited by this paper
• Analysis of chromosomal changes in serous ovarian carcinoma using high‐resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease

  2007cited by this paper
• Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

  2006cited by this paper
• Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice.

  2006cited by this paper
• MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior.

  2006cited by this paper
• microRNAs exhibit high frequency genomic alterations in human cancer.

  2006cited by this paper
• Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation.

  2006cited by this paper
• A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

  2006cited by this paper
• Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines.

  2006cited by this paper
• MicroRNA gene expression deregulation in human breast cancer.

  2005cited by this paper
• RAS is regulated by the let-7 microRNA family.

  2005influential reference
• MicroRNA expression profiles classify human cancers

  2005cited by this paper
• A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.

  2005cited by this paper
• Depletion of Human Micro-RNA miR-125b Reveals That It Is Critical for the Proliferation of Differentiated Cells but Not for the Down-regulation of Putative Targets during Differentiation*

  2005cited by this paper
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005cited by this paper
• miR-15 and miR-16 induce apoptosis by targeting BCL2.

  2005influential reference
• MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.

  2005cited by this paper
• Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

  2004cited by this paper
• Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

  2004cited by this paper
• High expression of precursor microRNA‐155/BIC RNA in children with Burkitt lymphoma

  2004cited by this paper
• ERBB2 amplification is superior to protein expression status in predicting patient outcome in serous ovarian carcinoma.

  2004cited by this paper
• A multistep model for ovarian tumorigenesis: the value of mutation analysis in the KRAS and BRAF genes

  2004cited by this paper
• The microRNA Registry

  2004cited by this paper
• Probing microRNAs with microarrays: tissue specificity and functional inference.

  2004cited by this paper
• Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation

  2004cited by this paper
• The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene

  2003cited by this paper
• MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing.

  2003influential reference
• Pathology of ovarian carcinoma.

  2003cited by this paper
• RNA interference

  2002cited by this paper
• Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

  2002cited by this paper
• Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

  2002cited by this paper
• Identification of Novel Genes Coding for Small Expressed RNAs

  2001cited by this paper
• Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers.

  2000cited by this paper
• Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.

  1999cited by this paper
• HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary.

  1999influential reference
• AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.

  1992cited by this paper
• Insight Review Articles

  year unknowncited by this paper

• Clinical utility of various liquid biopsy samples for the early detection of ovarian cancer: a comprehensive review

  2025cites this paper
• Integrated miRNA-mRNA Analyses of Triple-Negative Breast Cancer in Black and White Patients with or Without Obesity

  2025cites this paper
• The role of miR-429 in cancer: From biogenesis, signaling pathways, interactions with long non-coding RNAs, and function to therapeutic application.

  2025cites this paper
• miR-100: A key tumor suppressor regulatory factor in human malignant tumors (Review)

  2025cites this paper
• Role of EpCAM-Positive Exosomes in Ovarian Cancer: MiRNA Signatures of Chemoresistance and Disease Progression.

  2025cites this paper
• Olaparib increases chemosensitivity by upregulating miR-125a-3p in ovarian cancer cells

  2025cites this paper
• Engineered Extracellular Vesicles Enriched with the miR-214/199a Cluster Enhance the Efficacy of Chemotherapy for Ovarian Cancer

  2025cites this paper
• Simultaneous detection of ovarian cancer related miRNA biomarkers with carboxylated graphene oxide modified electrochemical biosensor platform.

  2024cites this paper
• Overexpression of miR-200s inhibits proliferation and invasion while increasing apoptosis in murine ovarian cancer cells

  2024cites this paper
• Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4

  2024cites this paper
• MicroRNA-enriched exosome as dazzling dancer between cancer and immune cells

  2024cites this paper
• Differential microRNA Expression Analysis in Patients with HPV-Infected Ovarian Neoplasms

  2024cites this paper
• Adipocyte derived exosomes promote cell invasion and challenge paclitaxel efficacy in ovarian cancer

  2024cites this paper
• Evolving Landscape of Detection and Targeting miRNA/Epigenetics for Therapeutic Strategies in Ovarian Cancer.

  2024cites this paper
• Identification of reference microRNAs in skeletal muscle of a canine model of Duchenne muscular dystrophy

  2024cites this paper
• MicroRNA-486-3p affects cisplatin resistance in high-grade serous ovarian cancer by regulating TMIGD2: An experimental study

  2024cites this paper
• Comparison of serum Vascular Cell Adhesion Molecule (VCAM) level among epithelial ovarian cancer patients and healthy women.

  2024cites this paper
• Interleukin-6 Modulation in Ovarian Cancer Necessitates a Targeted Strategy: From the Approved to Emerging Therapies

  2024cites this paper
• The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer

  2024cites this paper
• Determining the Diagnostic Strength of Serum Tumor Markers in Epithelial Ovarian Cancer in Women from Lahore, Pakistan

  2024cites this paper
• Exploring miRNA profile associated with cisplatin resistance in ovarian cancer cells

  2024cites this paper
• Profiles of differential expression of miRNAs in the late stage of red blood cell preservation and their potential roles.

  2024cites this paper
• The Role of MicroRNAs in Development of Endometrial Cancer: A Literature Review

  2023cites this paper
• Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer

  2023cites this paper
• Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer

  2023cites this paper
• Bioinformatic Analysis of miR-200b/429 and Hub Gene Network in Cervical Cancer

  2023cites this paper
• MicroRNA-21 promotes head and neck squamous cell carcinoma (HNSCC) induced transition of bone marrow mesenchymal stem cells to cancer-associated fibroblasts

  2023cites this paper
• A DNAzyme-enhanced nonlinear hybridization chain reaction for sensitive detection of microRNA

  2023cites this paper
• Blood Plasma Small Non-Coding RNAs as Diagnostic Molecules for the Progesterone-Receptor-Negative Phenotype of Serous Ovarian Tumors

  2023cites this paper
• Identification of Ovarian Cancer Using in Silico-Based Analysis of the Downregulated Expressed miRNAs

  2023cites this paper
• Circulating Biomarkers for Cancer Detection: Could Salivary microRNAs Be an Opportunity for Ovarian Cancer Diagnostics?

  2023cites this paper
• Evaluation of miRNA-21 and CA-125 as a promising diagnostic biomarker in patients with ovarian cancer

  2022cites this paper
• Role of epigallocatechin-3- gallate in the regulation of known and novel microRNAs in breast carcinoma cells

  2022cites this paper
• MicroRNA-199a-3p promotes drug sensitivity in triple negative breast cancer by down-regulation of BRCA1.

  2022cites this paper
• Whole transcriptome analysis reveals non-coding RNA's competing endogenous gene pairs as novel form of motifs in serous ovarian cancer

  2022cites this paper
• [MiR-125b-5 suppresses ovarian cancer cell migration and invasion by targeted downregulation of CD147].

  2022cites this paper
• Role, Significance, and Association of MicroRNA-10a/b in Physiology of Cancer.

  2022cites this paper
• Circular RNA’s competing endogenous gene pair as motif in serous ovarian cancer

  2022cites this paper
• Epi‐miRNAs: Modern mediators of methylation status in human cancers

  2022cites this paper
• Micro RNA the Important Biomarker in Cancer

  2022cites this paper
• Extracellular Vesicles from Uterine Aspirates Represent a Promising Source for Screening Markers of Gynecologic Cancers

  2022cites this paper
• Ascitic fluid shear stress in concert with hepatocyte growth factor drive stemness and chemoresistance of ovarian cancer cells via the c-Met-PI3K/Akt-miR-199a-3p signaling pathway

  2022cites this paper
• Ubiquitous Neural Cell Adhesion Molecule (NCAM): Potential Mechanism and Valorisation in Cancer Pathophysiology, Drug Targeting and Molecular Transductions

  2022cites this paper
• Search for New Participants in the Pathogenesis of High-Grade Serous Ovarian Cancer with the Potential to Be Used as Diagnostic Molecules

  2022cites this paper
• An Insight on the Role of Altered Function and Expression of Exosomes and MicroRNAs in Female Reproductive Diseases

  2021cites this paper
• A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer

  2021cites this paper
• Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis

  2021cites this paper
• Whole Transcriptome Analyses Identify Pairwise Gene Circuit Motif in Serous Ovarian Cancer

  2021cites this paper
• MicroRNAs as Biomarkers for Early Diagnosis, Prognosis, and Therapeutic Targeting of Ovarian Cancer

  2021cites this paper
• Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue

  2021cites this paper
• Mitochondrial DNA and MitomiR Variations in Pancreatic Cancer: Potential Diagnostic and Prognostic Biomarkers

  2021cites this paper
• Clinical significance of microRNA-200 and let-7 families expression assessment in patients with ovarian cancer

  2021influential citation
• miR-335 Restrains the Aggressive Phenotypes of Ovarian Cancer Cells by Inhibiting COL11A1

  2021cites this paper
• EPDR1, Which Is Negatively Regulated by miR-429, Suppresses Epithelial Ovarian Cancer Progression via PI3K/AKT Signaling Pathway

  2021cites this paper
• Simultaneous disruption of circulating miR‐21 and cytotoxic T lymphocytes (CTLs): Prospective diagnostic and prognostic markers for esophageal squamous cell carcinoma (ESCC)

  2021cites this paper
• Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer

  2021cites this paper
• Exploration of Potential miRNA Biomarkers and Prediction for Ovarian Cancer Using Artificial Intelligence

  2021cites this paper
• Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection

  2021cites this paper
• Ascites in ovarian cancer: MicroRNA deregulations and their potential roles in ovarian carcinogenesis

  2021cites this paper
• Epigenetic Mechanisms and Therapeutic Targets in Chemoresistant High-Grade Serous Ovarian Cancer

  2021cites this paper
• Applications of Multi-omics Approaches for Exploring the Molecular Mechanism of Ovarian Carcinogenesis

  2021cites this paper
• MicroRNA miR-145-5p inhibits Phospholipase D 5 (PLD5) to downregulate cell proliferation and metastasis to mitigate prostate cancer

  2021cites this paper
• Angiogenesis-related non-coding RNAs and gastrointestinal cancer

  2021cites this paper
• Current Implications of microRNAs in Genome Stability and Stress Responses of Ovarian Cancer

  2021cites this paper
• Plasma-derived exosomal miR-4732-5p is a promising noninvasive diagnostic biomarker for epithelial ovarian cancer

  2021cites this paper
• Exosomal miR‐21‐5p derived from cisplatin‐resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1

  2021cites this paper
• Small Non-Coding-RNA in Gynecological Malignancies

  2021cites this paper
• Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.

  2021cites this paper
• Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1

  2021cites this paper
• Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy

  2020cites this paper
• microRNA as Biomarker in Ovarian Cancer Management: Advantages and Challenges

  2020cites this paper
• Inhibition of microRNA let‐7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer

  2020cites this paper
• Bioinformatic screening for candidate biomarkers and their prognostic values in endometrial cancer

  2020cites this paper
• The Role of microRNAs in Epithelial Ovarian Cancer Metastasis

  2020cites this paper
• Mutually distinguishing microRNA signatures of breast, ovarian and endometrial cancers in vitro.

  2020cites this paper
• Effects of miR-93 on epithelial-to-mesenchymal transition and vasculogenic mimicry in triple-negative breast cancer cells

  2020cites this paper
• Epithelial/mesenchymal heterogeneity of high‐grade serous ovarian carcinoma samples correlates with miRNA let‐7 levels and predicts tumor growth and metastasis

  2020cites this paper
• MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway

  2020cites this paper
• Roles of microRNAs in Ovarian Cancer Tumorigenesis: Two Decades Later, What Have We Learned?

  2020cites this paper
• Expression of the miR-200 family in tumor tissue, plasma and urine of epithelial ovarian cancer patients in comparison to benign counterparts

  2020cites this paper
• Bioinformatics analysis of gene expression profile of serous ovarian carcinomas to screen key genes and pathways

  2020cites this paper
• OVER KANSERİ HÜCRELERİNDE PRİMA-1 Met TEDAVİSİNE YANIT OLARAK DEĞİŞEN miRNA EKSPRESYON ANALİZİ

  2020cites this paper
• Plasticity in Ovarian Cancer: The Molecular Underpinnings and Phenotypic Heterogeneity

  2020cites this paper
• The Suppression of miR-199a-3p by Promoter Methylation Contributes to Papillary Thyroid Carcinoma Aggressiveness by Targeting RAP2a and DNMT3a

  2020cites this paper
• miR-200b/200a/429 Cluster Stimulates Ovarian Cancer Development by Targeting ING5

  2020cites this paper
• MicroRNA-32 promotes ovarian cancer cell proliferation and motility by targeting SMG1

  2020cites this paper
• MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers

  2020cites this paper
• BCTT_A_269519 141..151

  2020cites this paper
• The prognostic role of microRNA in epithelial ovarian cancer: a systematic review of literature with an overall survival meta-analysis

  2020cites this paper
• Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender‐specific changes in the microRNA expression profiling in ME/CFS

  2020cites this paper
• Transcriptional factor Yin Yang 1 facilitates the stemness of ovarian cancer via suppressing miR-99a activity through enhancing its deacetylation level.

  2020cites this paper
• The Microrna-143/145 Cluster in Tumors: A Matter of Where and When

  2020cites this paper
• Role of Differential Expression of miRNAs miR-125a, miR-200a and miR-199a in Metastatic Property of Ovarian Cancer Cell lines and Relationship between miR-199a and its Predicted Target Protein GSK3β

  2020cites this paper
• Identification and Profiling of Pituitary microRNAs of Sheep during Anestrus and Estrus Stages

  2020cites this paper
• Evaluation of miR-22 and miR-21 as diagnostic biomarkers in patients with epithelial ovarian cancer

  2020cites this paper
• microRNAs as biomarkers of ovarian cancer

  2020cites this paper
• Preoperative

  2020cites this paper
• miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma

  2020cites this paper
• Screening Dys-Methylation Genes and Rules for Cancer Diagnosis by Using the Pan-Cancer Study

  2020cites this paper
• Identification and Functional Validation of Differentially Expressed microRNAs in Ascites-Derived Ovarian Cancer Cells Compared with Primary Tumour Tissue

  2020cites this paper